AU5319886A - Immunoregulatory peptides - Google Patents

Immunoregulatory peptides

Info

Publication number
AU5319886A
AU5319886A AU53198/86A AU5319886A AU5319886A AU 5319886 A AU5319886 A AU 5319886A AU 53198/86 A AU53198/86 A AU 53198/86A AU 5319886 A AU5319886 A AU 5319886A AU 5319886 A AU5319886 A AU 5319886A
Authority
AU
Australia
Prior art keywords
immunoregulatory peptides
immunoregulatory
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU53198/86A
Other versions
AU602483B2 (en
Inventor
Gary Scott Hahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunetech Pharmaceuticals
Original Assignee
Immunetech Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunetech Pharmaceuticals filed Critical Immunetech Pharmaceuticals
Publication of AU5319886A publication Critical patent/AU5319886A/en
Application granted granted Critical
Publication of AU602483B2 publication Critical patent/AU602483B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU53198/86A 1985-01-18 1986-01-15 Immunoregulatory peptides Ceased AU602483B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US69271185A 1985-01-18 1985-01-18
US80550485A 1985-11-29 1985-11-29
US80345285A 1985-11-29 1985-11-29
US803452 1985-11-29
US692711 1985-11-29
US805504 1985-11-29

Publications (2)

Publication Number Publication Date
AU5319886A true AU5319886A (en) 1986-08-13
AU602483B2 AU602483B2 (en) 1990-10-18

Family

ID=27418565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53198/86A Ceased AU602483B2 (en) 1985-01-18 1986-01-15 Immunoregulatory peptides

Country Status (3)

Country Link
EP (1) EP0215805A1 (en)
AU (1) AU602483B2 (en)
WO (1) WO1986004334A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU632526B2 (en) * 1989-01-13 1993-01-07 Richter Gedeon Vegyeszeti Gyar Rt. Novel peptides inhibiting the maturation of t-lymphocytes and the activity of macrophages, pharmaceutical compositions containing them and process for preparing same

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584284A (en) * 1985-01-31 1986-04-22 Ortho Pharmaceutical Corporation Bursopoietin
WO1989009225A1 (en) * 1988-03-28 1989-10-05 The Regents Of The University Of California Nerve growth factor peptides
GB8807427D0 (en) * 1988-03-28 1988-05-05 National Biological Standards Board Peptides
EP0335662B1 (en) * 1988-03-28 1995-07-26 Btg International Limited Peptides
HU201095B (en) * 1988-06-14 1990-09-28 Richter Gedeon Vegyeszet New peptides inhibiting the activity of the immune system and pharmaceutical compositions comprising same, as well as process for producing these peptides and compositions
EP0490379A3 (en) * 1990-12-13 1992-06-24 BERLIN-CHEMIE Aktiengesellschaft Diamino acid derivatives and pharmaceutical compositions
AU1749497A (en) * 1996-01-16 1997-08-11 Rensselaer Polytechnic Institute Peptides for altering osteoblast adhesion
US6126939A (en) * 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
WO1999009056A1 (en) * 1997-08-19 1999-02-25 University Of Medicine And Dentistry Of New Jersey Inhibition of hiv-1 replication using d-amino acid peptides
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
EP1141011A2 (en) * 1999-01-12 2001-10-10 Neorx Corporation Compounds and methods to inhibit or augment an inflammatory response
DE60033932T2 (en) * 1999-06-05 2007-12-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford METHOD AND COMPOSITION FOR INHIBITING CARDIOVASCULAR CELL PROLIFERATION
ATE510852T1 (en) * 2001-10-30 2011-06-15 Dsm Ip Assets Bv DERMOPHARMACEUTICALLY AND COSMETICALLY EFFECTIVE OLIGOPEPTIDES
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US9616011B2 (en) 2005-04-27 2017-04-11 The Procter & Gamble Company Personal care compositions
AR058736A1 (en) * 2005-12-29 2008-02-20 Ct Ingenieria Genetica Biotech MIMETIC PEPTIDES OF CARBOHYDRATES AND THEIR EMPLOYMENT IN PHARMACEUTICAL FORMULATIONS
US7612209B2 (en) * 2006-06-28 2009-11-03 Hoffmann-La Roche Inc. Pseudo proline dipeptides

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864481A (en) * 1972-12-14 1975-02-04 St Lukes Hospital Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
EP0033384B1 (en) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Medicaments containing fragments of thymosin-alpha-1 with immunostimulating activity, and thymosin-alpha-1 fragments
US4298523A (en) * 1980-06-17 1981-11-03 Ortho Pharmaceutical Corporation Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
US4370318A (en) * 1980-07-07 1983-01-25 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Bestatin-related compounds as immunopotentiator
US4361673A (en) * 1980-09-19 1982-11-30 American Home Products Corporation Polypeptide compositions
EP0056594B1 (en) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1 fragments and pharmaceutical compositions with immunoregulating action containing them
US4442031A (en) * 1981-10-15 1984-04-10 Hoffmann-La Roche Inc. Immunopotentiating peptides
US4390528A (en) * 1981-11-16 1983-06-28 Research Corporation Tuftsinyl-tuftsin
DE3146598A1 (en) * 1981-11-25 1983-07-07 Hoechst Ag, 6230 Frankfurt "NEW PEPTIDES AND METHOD FOR THEIR PRODUCTION"
DE3230151A1 (en) * 1982-08-13 1984-02-16 Hoechst Ag, 6230 Frankfurt NEW POLYPEPTIDE WITH EFFECT ON THE IMMUNE SYSTEM, METHOD FOR ITS INSULATION AND CLEANING, ITS USE, ITS CONTAINER, AND ITS DIFFERENT PRODUCTS, THEIR USE AND ITEMS
PT77368A (en) * 1982-09-27 1983-10-01 Lilly Co Eli Improved process for preparing immunomodulating agents or rela-ting there to
EP0114787B1 (en) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Peptide derivatives
FR2546756B1 (en) * 1983-06-03 1985-11-29 Centre Nat Rech Scient NOVEL IMMUNOSTIMULATING DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2549724B1 (en) * 1983-07-29 1986-04-18 Sanyo Machine Works CARCINOSTATIC AGENT HAVING AN IMMUNOPOTENTIALIZING CARCINOSTATIC EFFECT WHICH CONTAINS EISENINE (TRIPEPTIDE) AS ACTIVE INGREDIENT
DE3401545A1 (en) * 1983-08-03 1985-02-14 Hoechst Ag, 6230 Frankfurt NEW PEPTIDES WITH IMMUNE-STIMULATING EFFECT, METHOD FOR THE PRODUCTION AND THEIR USE
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
DE3421614A1 (en) * 1984-06-09 1985-12-12 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING PENTAPEPTIDES WITH EFFECT ON THE IMMUNE SYSTEM AND INTERMEDIATE PRODUCTS OF THIS METHOD
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU632526B2 (en) * 1989-01-13 1993-01-07 Richter Gedeon Vegyeszeti Gyar Rt. Novel peptides inhibiting the maturation of t-lymphocytes and the activity of macrophages, pharmaceutical compositions containing them and process for preparing same

Also Published As

Publication number Publication date
WO1986004334A1 (en) 1986-07-31
EP0215805A1 (en) 1987-04-01
AU602483B2 (en) 1990-10-18

Similar Documents

Publication Publication Date Title
AU5274386A (en) Peptidylaminodiols
AU590362B2 (en) Uv-dosimeter
AU5893286A (en) 2-arylimidazoles
AU5184886A (en) Somatostatines
AU5391286A (en) Trechter
AU569194B2 (en) 5-hydroxy-2-amino-pyrimidines
AU5319886A (en) Immunoregulatory peptides
AU590016B2 (en) Peptides
AU590605B2 (en) Gamma-carbolines
AU576731B2 (en) Undermattress
AU586848B2 (en) Spiro-dioxolanes, - dithiolanes and-oxothiolanes
AU5313686A (en) Verktygsstal
AU5519386A (en) Epicondylitis-bandage
AU5514686A (en) Piperazinecarboxamides
AU5392186A (en) Picfilcylinder
AU6208886A (en) Peptide antibiotics
AU586903B2 (en) 1-aryl-pyrazoles
GB8608140D0 (en) Peptides
AU563024B2 (en) Dihydropyridien
AU586307B2 (en) 1-aryl-pyrazoles
AU5352786A (en) Nasen-kapseln
AU5452286A (en) Wellenenergieanlage
AU4805485A (en) Schlauchbeutelpackung
AU5352386A (en) Vedenalainen tartuntamenetelma ja-valine
AU5232686A (en) Ferry-boat